GVR Report cover Sepsis Diagnostics Market Size, Share & Trends Report

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology, By Pathogen, By Testing Type, By Method, By End-user, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-352-2
  • Number of Report Pages: 120
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Sepsis Diagnostics Market Size & Trends

The global sepsis diagnostics market size was estimated at USD 1.07 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. Factors such as the introduction of technologically advanced diagnostic and treatment solutions, high prevalence of sepsis, and increasing awareness are responsible for market growth over the forecast period. Sepsis is the leading cause of death in high-income countries, such as the U.S., with approximately 270,000 people dying from the condition annually, according to the Centers for Disease Control and Prevention (CDC).

U.S. sepsis diagnostics Market size and growth rate, 2024 - 2030

It is also prevalent in low and middle-income countries, where it often is undiagnosed and untreated due to limited access to healthcare. In 2020, the Global Sepsis Alliance reported that it is responsible for an estimated 11 million deaths worldwide each year, which is more than the combined number of deaths from breast cancer, prostate cancer, and HIV/AIDS. The situation is particularly severe in low-income countries, where disease-related mortality is the highest. As such, there is an urgent need for improving awareness, prevention, and treatment, particularly in these regions.

Pneumonia is the leading cause of sepsis and septic shock, affecting individuals of all ages. While community-acquired pneumonia and hospital-acquired pneumonia differ in symptom duration, both can result in severe pneumonia and an increased risk of developing sepsis. Recent studies indicate that sepsis is a direct outcome of pneumonia, with more than half of patients having suffered from pneumonia. Pneumonia and sepsis cases have significantly increased globally as a result of the COVID-19 pandemic. A study published in The Lancet Respiratory Medicine in August 2021 indicates that the prevalence of sepsis and mortality linked to sepsis have considerably increased throughout the pandemic.

The COVID-19 pandemic has further highlighted the importance of early diagnosisand treatment, as it can lead to organ dysfunction and increasing risk of developing sepsis. While the pathogenesis of COVID-19 is not yet fully understood, research suggests that cytokine and chemokine levels in severe COVID-19 patients are similar to those found in patients, highlighting the need for improved diagnostic tools for sepsis. Some companies offering advanced diagnostics for the disease are T2 Biosystems, Becton, Dickinson and Company (BD), and F. Hoffmann-La Roche. These companies are actively involved in developing diagnostic tools to provide faster and more accurate diagnosis, improve patient outcomes, and reduce the global burden of disease.

Hospital-acquired infections continue to be a major contributor to the development of sepsis diagnostics, particularly among patients with chronic conditions, such as diabetes. CDC reports that approximately 1 in 31 hospital patients in the U.S. acquires hospital-acquired infection each year. These infections often result from invasive medical procedures, such as catheter insertions, and can lead to sepsis. Catheter-Associated Urinary Tract Infections (CAUTIs) and Surgical Site Infections (SSIs) are the most common types of hospital-acquired infections.

Market Concentration & Characteristics

Market growth stage is high, and pace of the market growth is accelerating. The space is characterized by a high degree of innovation. The sepsis diagnostics market is being driven by technological advancements, such as molecular diagnostic technologies, multiplex assays, and biomarkers. For example, Roche diagnostics offers products, such as the Elecsys BRAHMS PCT assay, which measures the levels of PCT in the blood. Several emerging trends are likely to shape market in the future. These include development of POC diagnostic tools, an integration of Al & machine learning algorithms into diagnostics, and growing use of biomarkers for disease diagnosis.

Sepsis Diagnostics Market Concentration & Characteristics

Regulatory bodies are crucial in driving the market, setting standards and guidelines for product development and approval. Recent trends show a focus on streamlining approval processes, promoting innovative technologies, and evidence- based clinical practices. The FDA has approved T2Bacteria Panel, which detects the disease-causing bacteria directly from a patient's blood sample, without waiting for cultures to grow, which is an example of this trend, likely to drive market during the forecast period.

Despite the advancements, several challenges still exist in the market. Some of the significant challenges facing the market include the high cost of diagnostics tests, the lack of awareness about the disease & its diagnosis, and the limited availability of diagnostic tools in developing countries.

The market substitutes revolves around alternative and traditional methods to identify infections. The emergence of new technologies and diagnostic tools poses a potential challenge to traditional sepsis detection approaches. As these substitutes advance, healthcare providers may weigh the pros and cons, potentially impacting the market landscape for sepsis diagnostics.

Market Dynamics

The market is driven by technological advancements, such as molecular diagnostic technologies, multiplex assays, and biomarkers. For example, Roche Diagnostics offers products, such as the Elecsys BRAHMS PCT assay, which measures the levels of PCT in the blood. Several emerging trends are likely to shape market in the future. These include developing POC diagnostic tools, integrating Al & machine learning algorithms into diagnostics, and using biomarkers for disease diagnosis.

Regulatory bodies are crucial in driving the market and setting standards and guidelines for product development and approval. Recent trends focus on streamlining approval processes, promoting innovative technologies, and evidence-based clinical practices. The FDA has approved T2Bacteria Panel, which detects the disease-causing bacteria directly from a patient's blood sample without waiting for cultures to grow. This trend is likely to drive market growth during the forecast period.

Despite the advancements, several challenges still exist in the market. Some of the significant challenges facing the market include the high cost of diagnostics tests, the lack of awareness about the disease & its diagnosis, and the limited availability of diagnostic tools in developing countries.

Product Insights

Based on product type, blood culture media dominated the market in 2023 with a revenue share of more than 38.9%, as blood culture is considered the most cost-effective and convenient testing mode. In April 2019, BD launched the BD BACTEC platelet quality control media, which can help identify and decrease the incidence in patients receiving platelet transfusion. It enables blood banks, microbiology laboratories, and transfusion services to detect contaminated platelet units. Introduction of such new media is expected to fuel the segment’s growth.

Assay kits & reagents segment is estimated to register the fastest CAGR during the forecast period. Assay kits with different analyzers provide high-throughput analytical outcomes for disease detection. For instance, VIDAS B.R.A.H.M.S. PCT by bioMérieux SA aids in the early detection of sepsis causing microorganisms through PCT discovery in human serum or plasma; it provides results in approximately 20 minutes.Major kits & reagents by leading manufacturers are penetrating major markets through new product developments & launches. For instance, in May 2021, Ortho Clinical Diagnostics released the VITROS Immunodiagnostic Products IL-6 Reagent Pack as a part of the company’s VITROS Critical Care menu.

Technology Insights

The microbiology technology segment dominated the market in 2023 and held the largest share of more than 48.9% of the overall revenue. Microbial culture is the primary and gold standard method for detecting infectious disease-causing organisms in laboratory settings.In addition, new strategic initiatives by key players will further drive the segment growth in near future. For instance, in April 2019, BD launched BD BACTEC platelet quality control media, which enables users to identify and decrease the incidence in patients receiving platelet transfusion.

Molecular diagnostics segment is anticipated to expand at the fastest CAGR over the coming years. Molecular diagnostic technique is another crucial tool in the detection of sepsis. It also assists in reducing the time of pathogen identification, thus allowing early detection and initiation of treatment at a faster rate as compared to conventional diagnostic methods. Methicillin-resistant Staphylococcus Aureus (MRSA) most commonly causes skin infections.PCR and Nucleic Acid Sequence-based Amplification (NASBA) are used to detect MRSA. However, the molecular diagnostic technique is considered the standard pathogen identification technique after blood culture.

Pathogen Insights

Bacterial segment held the largest revenue share of 86.0% of the market in 2023. It is anticipated to lead over the forecast period due to the rise in cases of bacterial sepsis, higher occurrence of hospital-transmitted infections, and rising number of surgical procedures conducted. According to the study published by SAGE Journals in January 2019, bacterial segment is the most common type, with 62.2% of patients infected with gram-negative bacteria and 46.8% with gram-positive bacteria. In the bacterial segment, the gram-negative bacteria sub-segment is anticipated to dominate the market over the forecast period.

The fungal segment is expected to grow at a significant CAGR over the forecast period. One of the major drivers is the increasing availability and introduction of a new and wide range of disease diagnosis devices for pathogen detection. One of the vital tests used to detect fungal infections is an ELISA developed by Laboratory Corporation of America Holdings. This assay is used to detect IgG, IgA, and IgM antibodies to Candida albicans, a major cause of bloodstream infection leading to septic shock & sepsis. BacT/ALERT Culture Media by bioMérieux SA and BD BACTEC Media by BD are other crucial products available in the market for the isolation & identification of fungal sepsis.

Method Insights

The conventional diagnostics segment held the largest revenue share of 57.6% of the market in 2023. The conventional method relies on the expertise of healthcare professionals to evaluate the patient's clinical presentation and interpret laboratory and imaging results. Early detection and prompt treatment are crucial to improve patient outcomes.

The automated diagnostic method is the fastest-growing segment over the forecast period. Clinical Decision Support Systems (CDSS), Machine learning algorithms, biomarkers, and continuous monitoring systems are some of the automated diagnostics methods available for diagnostics. Continuous monitoring systems, such as wearable devices and implantable sensors, can track vital signs and other clinical data in real-time. These systems can detect changes in a patient's condition that may indicate the disease and alert healthcare professionals for prompt intervention.

End-user Insights

The hospital and clinics segment held the largest revenue size of 79.5% of the market in 2023, owing to an increase in hospitalization. Several ongoing developments to advance diagnostic tests are anticipated to boost the segment. In January 2023, FDA authorized IntelliSep, a novel diagnostic test that can assist in identifying patients with sepsis before the potentially fatal condition becomes too difficult to treat. Early detection is crucial for proper results as sepsis is responsible for one in three hospital deaths.

Pathology & reference laboratories are estimated to be the fastest end-user segment over the forecast period. Reference laboratories play an important role in sepsis diagnostics by providing specialized testing services unavailable in most hospitals or clinics. Presence of several pathology and reference laboratories globally, which offer a comprehensive range of testing services for sepsis, has further contributed to segment growth. For instance, Arup Laboratories offers specialized testing services for sepsis. Its offerings include blood culture testing, biomarker testing, and PCR testing for specific pathogens.

Testing Type Insights

The laboratory testing type segment dominated the market in 2023 with a share of 82.6%. Advancements in laboratory testing have made it easier and faster to detect sepsis, leading to better outcomes for patients. These tests use biomarkers, such as procalcitonin or cytokines, to identify the presence of infection in the body. The tests are sensitive and can provide results within hours, allowing for earlier detection and treatment of sepsis. Thus, these factors would further contribute to the development of more effective and personalized approaches to diagnosis.

Global sepsis diagnostics Market share and size, 2023

PoC testing is estimated to grow at a significant CAGR over the forecast period. Technological advancements in POC test kits in terms of shorter turnaround times and error-free results are expected to boost the market in the future.Various manufacturers are focusing on the development of novel POC testing kits for early detection of the disease.In January 2021, Inflammatix gained USD 32 million in Series C funding to support the commercial launch of its rapid HostDx test in the European market and its submission to the FDA in the same year.

Regional Insights

North America dominated the market in 2023 and held the largest revenue share of more than 44.4%. High incidence of sepsis and infectious diseases is expected to fuel demand for novel diagnostic solutions. Several developments have been reported in the region, contributing to market growth. For instance, in January 2023, Cytovale announced receiving FDA authorization for its IntelliSep Sepsis Test for early detection of sepsis.

sepsis diagnostics Market Trends, by Region, 2024 - 2030

Asia Pacific is estimated to be the fastest-growing regional market from 2024 to 2030, majorly attributed to rising demand for diagnostic solutions in countries with a high prevalence of infectious diseases, such as China and India. Furthermore, constant developments in molecular diagnostics technology, such as the introduction of Point-Of-Care (POC) testing devices & next-generation sequencing technology, and integration of machine learning & artificial intelligence, contributing to the region’s market growth. For instance, In January 2023, Asep Medical Holdings, Inc. entered into a joint venture with Sansure Biotech Inc., a medical diagnostics company, in China to commercialize Sepset(ER) Sepsis Diagnostic Test in the country.

Key Companies & Market Share Insights

Some of the key players operating in the industry are BD, bioMérieux SA, and Thermo Fisher Scientific, Inc.. The leading players in industry are focusing on growth strategies, such as innovations with product, and R&D investments.These companies have strong supply chain, which enables them to meet the demands of customers in a timely and efficient manner leading to increase in their revenue share

Immunexpress, Inc., and Luminex Corp. are some of the emerging market participants in the space. Emerging companies are employing various strategies such as mergers & acquisitions to expand their hold and grow at a fast pace.Companies in this category have lower production capacity and financial capability compared to leaders but are in line with industry trends. They focus on innovation and development of new products and technologies to meet market demands.

Key Sepsis Diagnostics Companies:

  • BD, Becton, Dickinson & Company
  • bioMérieux SA
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation (Beckman Coulter, Inc.)
  • F. Hoffmann-La Roche AG
  • Cepheid
  • Luminex Corp.
  • Koninklijke Philips N.V.
  • Bruker
  • Immunexpress, Inc.

Recent Developments

  • In February 2023, Immunexpress commercialized its SeptiCyte Rapid test in the U.S., which can quickly diagnose sepsis in patients within an hour. The point-of-care test can help clinicians identify patients at an earlier stage, leading to timely intervention and better outcomes.

  • In January 2023, Cytovale announced launch of its new IntelliSep sepsis diagnostics test. The new test is launched to address patients in emergency department suffering from sepsis.

  • In January 2023, PERSOWN Inc. launched SMASH-H, a real-time sepsis monitoring system with an aim to address increasing burden of sepsis.

Sepsis Diagnostics Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 1.15 billion

Revenue forecast in 2030

USD 1.82 billion

Growth rate

CAGR of 8.0% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD billion/million and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Product, technology, pathogen, testing type, method, end-user, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; UK; Germany; Spain; France; Italy; Russia; Denmark; Sweden; Norway; Japan; India; China; South Korea; Singapore; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

bioMérieux SA; Becton, Dickinson & Company; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Danaher Corporation (Beckman Coulter, Inc.); Luminex Corp.; Bruker; Cepheid; Immunexpress, Inc.; Koninklijke Philips N.V.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Sepsis Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sepsis diagnostics market report based on product, method, end-user, technology, pathogen, testing type, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Instruments

    • Blood Culture Media

    • Assay Kits and Reagents

    • Software

  • Technology Outlook (Revenue, USD Million, 2018 - 2030)

    • Microbiology

    • Molecular Diagnostics

      • Polymerase Chain Reaction (PCR)

      • DNA Microarrays

      • Syndromic Panel testing

      • Others

    • Immunoassays

    • Flow Cytometry

    • Others

  • Pathogen Outlook (Revenue, USD Million, 2018 - 2030)

    • Bacterial Sepsis

      • Gram-positive Bacteria

      • Gram-negative Bacteria

    • Fungal Sepsis

    • Viral Sepsis

    • Others

  • Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Laboratory Testing

    • PoC Testing

  • Method Outlook (Revenue, USD Million, 2018 - 2030)

    • Automated Diagnostics

    • Conventional Diagnostics

  • End-user Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals & Clinics

    • Pathology & Reference Laboratories

    • Research Institutes and Others

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

      • Spain

      • France

      • Italy

      • Russia

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Singapore

      • Australia

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1 Sepsis Diagnostics Market: Methodology and Scope
                  1.1 Market Segmentation And Scope
                  1.1 Market Definitions
                      1.1.1 Estimates And Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database:
                      1.3.2 GVR’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                      1.3.5 Details Of Primary Research
                  1.4 Information Or Data Analysis
                      1.4.1 Data Analysis Models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis
                          1.6.1.1 Approach: Commodity Flow Approach
                  1.7 Research Assumptions
                  1.8 List Of Secondary Sources
                  1.9 List Of Abbreviations
                  1.10 Objectives
                      1.10.1 Objective 1
                      1.10.2 Objective 2
                      1.10.3 Objective 3
                      1.10.4 Objective 4
Chapter 2 Sepsis Diagnostics Market: Executive Summary
                  2.1 Market Snapshot
                  2.2 Product And Technology Snapshot
                  2.3 Pathogen And Testing Type Snapshot
                  2.4 Method And End-user Snapshot
                  2.5 Competitive Landscape Snapshot
Chapter 3 Sepsis Diagnostics Market: Variables, Trends & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market Outlook
                      3.1.2 Related/ancillary Market Outlook
                  3.2 Market Dynamics
                      3.2.1 Market Driver Impact Analysis
                          3.2.1.1 Increase In Prevalence Of Sepsis
                          3.2.1.2 Rise In Incidence Of Hospital-acquired Infections
                          3.2.1.3 Increase In The Number Of Pneumonia Cases
                          3.2.1.4 Approval And Launch Of Advanced Sepsis Diagnostic System
                      3.2.2 Market Restraint Analysis
                          3.2.2.1 High Cost Of Automated Diagnostic Instruments
                          3.2.2.2 Lack Of Awareness About Sepsis
                      3.2.3 Industry Challenges
                          3.2.3.1 Scientific And Clinical Challenges Associated With Sepsis
                  3.3 Sepsis Diagnostics: Market Analysis Tools
                      3.3.1 Porter’s Analysis
                      3.3.2 Sepsis Diagnostics - Macroeconomic Analysis
Chapter 4 Sepsis Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
                  4.1 Sepsis Diagnostics Market: Product Movement Analysis
                  4.2 Sepsis Diagnostics Market Estimates & Forecast, By Product (USD Million)
                      4.2.1 Instrument
                      4.2.2 Blood Culture Media
                      4.2.3 Assay Kits And Reagents
                      4.2.4 Software
Chapter 5 Sepsis Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)
                  5.1 Sepsis Diagnostics Market: Technology Movement Analysis
                  5.2 Sepsis Diagnostics Market Estimates & Forecast, By Technology (USD Million)
                      5.2.1 Microbiology
                      5.2.2 Molecular Diagnostics
                          5.2.2.1 Polymerase Chain Reaction (Pcr)
                          5.2.2.2 Dna Microarrays
                          5.2.2.3 Syndromic Panel Testing
                          5.2.2.4 Others
                      5.2.3 Immunoassays
                      5.2.4 Flow Cytometry
                      5.2.5 Others
Chapter 6 Sepsis Diagnostics Market: Segment Analysis, By Pathogen, 2018 - 2030 (USD Million)
                  6.1 Sepsis Diagnostics Market: Pathogen Movement Analysis
                  6.2 Sepsis Diagnostics Market Estimates & Forecast, By Pathogen (USD Million)
                      6.2.1 Bacterial Sepsis
                          6.2.1.1 Gram-positive Bacteria
                          6.2.1.2 Gram-negative Bacteria
                      6.2.2 Fungal Sepsis
                      6.2.3 Viral Sepsis And Others
Chapter 7 Sepsis Diagnostics Market: Segment Analysis, By Testing Type, 2018 - 2030 (USD Million)
                  7.1 Sepsis Diagnostics Market: Testing Type Movement Analysis
                  7.2 Sepsis Diagnostics Market Estimates & Forecast, By Testing Type (USD Million)
                      7.2.1 Laboratory Testing
                      7.2.2 Point-of-care Testing
Chapter 8 Sepsis Diagnostics Market: Segment Analysis, By Method, 2018 - 2030 (USD Million)
                  8.1 Sepsis Diagnostics Market: Method Movement Analysis
                  8.2 Sepsis Diagnostics Market Estimates & Forecast, By Method (USD Million)
                      8.2.1 Automated Diagnostics
                      8.2.2 Conventional Diagnostics
Chapter 9 Sepsis Diagnostics Market: Segment Analysis, By End-user, 2018 - 2030 (USD Million)
                  9.1 Sepsis Diagnostics Market: End-user Movement Analysis
                  9.2 Sepsis Diagnostics Market Estimates & Forecast, By End-user (USD Million)
                      9.2.1 Hospitals & Clinics
                      9.2.2 Pathology & Reference Laboratories
                      9.2.3 Research Institutes And Others
Chapter 10 Sepsis Diagnostic Market: Regional Estimates And Trend Analysis, By Product, By Technology, By Pathogen, By Testing Type, By Method, & By End-user
                  10.1 Sepsis Diagnostic Market: Regional Outlook
                  10.2 North America
                      10.2.1 North America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.2.1.1 Regulatory Framework
                          10.2.1.2 Reimbursement Scenario
                      10.2.2 U.s.
                          10.2.2.1 Key Country Dynamics
                          10.2.2.2 U.s. Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.2.2.3 Market & Competitive Scenario
                      10.2.3 Canada
                          10.2.3.1 Key Country Dynamics
                          10.2.3.2 Canada Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.2.3.3 Market And Competitive Scenario
                  10.3 Europe
                      10.3.1 Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.1.1 Regulatory Framework
                          10.3.1.2 Reimbursement Scenario
                      10.3.2 Uk
                          10.3.2.1 Key Country Dynamics
                          10.3.2.2 Uk Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.2.3 Market & Competitive Scenario
                      10.3.3 Germany
                          10.3.3.1 Key Country Dynamics
                          10.3.3.2 Germany Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.3.3 Market & Competitive Scenario
                      10.3.4 France
                          10.3.4.1 Key Country Dynamics
                          10.3.4.2 France Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.4.3 Market & Competitive Scenario
                      10.3.5 Spain
                          10.3.5.1 Key Country Dynamics
                          10.3.5.2 Spain Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.5.3 Market & Competitive Scenario
                      10.3.6 Italy
                          10.3.6.1 Key Country Dynamics
                          10.3.6.2 Italy Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.6.3 Market & Competitive Scenario
                      10.3.7 Denmark
                          10.3.7.1 Key Country Dynamics
                          10.3.7.2 Denmark Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.7.3 Market & Competitive Scenario
                      10.3.8 Sweden
                          10.3.8.1 Key Country Dynamics
                          10.3.8.2 Sweden Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.8.3 Market & Competitive Scenario
                      10.3.9 Norway
                          10.3.9.1 Key Country Dynamics
                          10.3.9.2 Norway Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.9.3 Market & Competitive Scenario
                      10.3.10 Russia
                          10.3.10.1 Key Country Dynamics
                          10.3.10.2 Russia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.3.10.3 Market & Competitive Scenario
                          10.3.10.4 Rest Of Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                  10.4 Asia Pacific
                      10.4.1 Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.1.1 Regulatory Framework
                          10.4.1.2 Reimbursement Scenario
                      10.4.2 Japan
                          10.4.2.1 Key Country Dynamics
                          10.4.2.2 Japan Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.2.3 Market And Competitive Scenario
                      10.4.3 China
                          10.4.3.1 Key Country Dynamics
                          10.4.3.2 China Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.3.3 Market And Competitive Scenario
                      10.4.4 India
                          10.4.4.1 Key Country Dynamics
                          10.4.4.2 India Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.4.3 Market And Competitive Scenario
                      10.4.5 Australia
                          10.4.5.1 Key Country Dynamics
                          10.4.5.2 Australia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.5.3 Market And Competitive Scenario
                      10.4.6 Thailand
                          10.4.6.1 Key Country Dynamics
                          10.4.6.2 Thailand Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.6.3 Market And Competitive Scenario
                      10.4.7 South Korea
                          10.4.7.1 Key Country Dynamics
                          10.4.7.2 South Korea Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.7.3 Market And Competitive Scenario
                      10.4.8 Singapore
                          10.4.8.1 Key Country Dynamics
                          10.4.8.2 Singapore Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.4.8.3 Market And Competitive Scenario
                          10.4.8.4 Rest Of Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                  10.5 Latin America
                      10.5.1 Latin America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.5.1.1 Regulatory Framework
                          10.5.1.2 Reimbursement Scenario
                      10.5.2 Brazil
                          10.5.2.1 Key Country Dynamics
                          10.5.2.2 Brazil Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.5.2.3 Market And Competitive Scenario
                      10.5.3 Mexico
                          10.5.3.1 Key Country Dynamics
                          10.5.3.2 Mexico Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.5.3.3 Market And Competitive Scenario
                      10.5.4 Argentina
                          10.5.4.1 Key Country Dynamics
                          10.5.4.2 Argentina Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.5.4.3 Market And Competitive Scenario
                          10.5.4.4 Rest Of Latam Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                  10.6 MEA
                      10.6.1 MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.6.1.1 Regulatory Framework
                          10.6.1.2 Reimbursement Scenario
                      10.6.2 South Africa
                          10.6.2.1 Key Country Dynamics
                          10.6.2.2 South Africa Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.6.2.3 Market And Competitive Scenario
                      10.6.3 Saudi Arabia
                          10.6.3.1 Key Country Dynamics
                          10.6.3.2 Saudi Arabia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.6.3.3 Market And Competitive Scenario
                      10.6.4 UAE
                          10.6.4.1 Key Country Dynamics
                          10.6.4.2 UAE Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.6.4.3 Competitive Scenario
                      10.6.5 Kuwait
                          10.6.5.1 Key Country Dynamics
                          10.6.5.2 Kuwait Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
                          10.6.5.3 Market And Competitive Scenario
                          10.6.5.4 Rest Of MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 11 Competitive Landscape
                  11.1 Company Categorization
                  11.2 Company Market Positioning
                      11.2.1 Market Leaders
                          11.2.1.1 Sepsis Diagnostics Market Share Analysis, 2023
                  11.3 Company Profiles
                  11.3 Company Profiles
                      11.3.1 Biomérieux Sa
                          11.3.1.1 Company Overview
                          11.3.1.2 Financial Performance
                          11.3.1.3 Product Benchmarking
                          11.3.1.4 Strategic Initiatives
                      11.3.2 Becton, Dickinson And Company (Bd)
                          11.3.2.1 Company Overview
                          11.3.2.2 Financial Performance
                          11.3.2.3 Product Benchmarking
                          11.3.2.4 Strategic Initiatives
                      11.3.3 Thermo Fisher Scientific, Inc.
                          11.3.3.1 Company Overview
                          11.3.3.2 Financial Performance
                          11.3.3.3 Product Benchmarking
                          11.3.3.4 Strategic Initiatives
                      11.3.4 F. Hoffmann-la Roche
                          11.3.4.1 Company Overview
                          11.3.4.2 Financial Performance
                          11.3.4.3 Product Benchmarking
                          11.3.4.4 Strategic Initiatives
                      11.3.5 Luminex Corporation
                          11.3.5.1 Company Overview
                          11.3.5.2 Financial Performance
                          11.3.5.3 Product Benchmarking
                          11.3.5.4 Strategic Initiatives
                      11.3.6 Danaher (Beckman Coulter, Inc.)
                          11.3.6.1 Company Overview
                          11.3.6.2 Financial Performance
                          11.3.6.3 Product Benchmarking
                          11.3.6.4 Strategic Initiatives
                      11.3.7 Bruker Corporation
                          11.3.7.1 Company Overview
                          11.3.7.2 Financial Performance
                          11.3.7.3 Product Benchmarking
                          11.3.7.4 Strategic Initiatives
                      11.3.8 Cepheid
                          11.3.8.1 Company Overview
                          11.3.8.2 Financial Performance
                          11.3.8.3 Product Benchmarking
                          11.3.8.4 Strategic Initiatives
                      11.3.9 Koninklijke Philips N.v.
                          11.3.9.1 Company Overview
                          11.3.9.2 Financial Performance
                          11.3.9.3 Product Benchmarking
                          11.3.9.4 Strategic Initiatives
                      11.3.10 Immunexpress, Inc.
                          11.3.10.1 Company Overview
                          11.3.10.2 Financial Performance
                          11.3.10.3 Product Benchmarking
                          11.3.10.4 Strategic Initiatives


List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 4 North America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 5 North America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 6 North America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 7 North America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 8 North America sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 9 North America sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 10 North America sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 11 U.S. sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 U.S. sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 13 U.S. sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 14 U.S. sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 15 U.S. sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 16 U.S. sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 17 U.S. sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 18 Canada sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 19 Canada sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 20 Canada sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 21 Canada sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 22 Canada sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 23 Canada sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 24 Canada sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 25 Europe sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 26 Europe sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 27 Europe sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 28 Europe sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 29 Europe sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 30 Europe sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 31 Europe sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 32 Europe sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 33 Germany sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 34 Germany sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 35 Germany sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 36 Germany sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 37 Germany sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 38 Germany sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 39 Germany sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 40 UK sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 41 UK sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 42 UK sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 43 UK sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 44 UK sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 45 UK sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 46 UK sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 47 France sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 48 France sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 49 France sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 50 France sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 51 France sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 52 France sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 53 France sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 54 Italy sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 55 Italy sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 56 Italy sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 57 Italy sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 58 Italy sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 59 Italy sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 60 Italy sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 61 Spain sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 62 Spain sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 63 Spain sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 64 Spain sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 65 Spain sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 66 Spain sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 67 Spain sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 68 Russia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 69 Russia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 70 Russia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 71 Russia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 72 Russia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 73 Russia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 74 Russia sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 75 Denmark sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 76 Denmark sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 77 Denmark sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 78 Denmark sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 79 Denmark sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 80 Denmark sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 81 Denmark sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 82 Sweden sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 83 Sweden sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 84 Sweden sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 85 Sweden sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 86 Sweden sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 87 Sweden sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 88 Sweden sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 89 Norway sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 90 Norway sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 91 Norway sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 92 Norway sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 93 Norway sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 94 Norway sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 95 Norway sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 96 Asia Pacific sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 97 Asia Pacific sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 98 Asia Pacific sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 99 Asia Pacific sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 100 Asia Pacific sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 101 Asia Pacific sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 102 Asia Pacific sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 103 Asia Pacific sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 104 China sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 105 China sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 106 China sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 107 China sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 108 China sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 109 China sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 110 China sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 111 India sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 112 India sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 113 India sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 114 India sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 115 India sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 116 India sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 117 India sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 118 Australia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 119 Australia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 120 Australia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 121 Australia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 122 Australia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 123 Australia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 124 Australia sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 125 Japan sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 126 Japan sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 127 Japan sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 128 Japan sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 129 Japan sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 130 Japan sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 131 Japan sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 132 South Korea sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 133 South Korea sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 134 South Korea sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 135 South Korea sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 136 South Korea sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 137 South Korea sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 138 South Korea sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 139 Singapore sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 140 Singapore sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 141 Singapore sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 142 Singapore sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 143 Singapore sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 144 Singapore sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 145 Singapore sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 146 Thailand sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 147 Thailand sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 148 Thailand sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 149 Thailand sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 150 Thailand sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 151 Thailand sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 152 Thailand sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 153 Latin America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 154 Latin America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 155 Latin America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 156 Latin America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 157 Latin America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 158 Latin America sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 159 Latin America sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 160 Latin America sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 161 Brazil sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 162 Brazil sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 163 Brazil sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 164 Brazil sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 165 Brazil sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 166 Brazil sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 167 Brazil sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 168 Mexico sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 169 Mexico sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 170 Mexico sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 171 Mexico sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 172 Mexico sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 173 Mexico sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 174 Mexico sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 175 Argentina sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 176 Argentina sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 177 Argentina sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 178 Argentina sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 179 Argentina sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 180 Argentina sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 181 Argentina sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 182 MEA sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 183 MEA sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 184 MEA sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 185 MEA sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 186 MEA sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 187 MEA sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 188 MEA sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 189 MEA sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 190 South Africa sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 191 South Africa sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 192 South Africa sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 193 South Africa sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 194 South Africa sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 195 South Africa sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 196 South Africa sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 197 Saudi Arabia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 198 Saudi Arabia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 199 Saudi Arabia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 200 Saudi Arabia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 201 Saudi Arabia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 202 Saudi Arabia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 203 Saudi Arabia sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 204 UAE sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 205 UAE sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 206 UAE sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 207 UAE sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 208 UAE sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 209 UAE sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 210 UAE sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
Table 211 Kuwait sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 212 Kuwait sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 213 Kuwait sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
Table 214 Kuwait sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
Table 215 Kuwait sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
Table 216 Kuwait sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
Table 217 Kuwait sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Sepsis diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Segment snapshot
Fig. 12 Segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Sepsis diagnostics market dynamics
Fig. 15 Porter’s Five Force Analysis
Fig. 16 Sepsis diagnostics market: PESTEL analysis
Fig. 17 Sepsis diagnostics market: Product outlook and key takeaways
Fig. 18 Sepsis diagnostics market: Product movement analysis
Fig. 19 Instrument sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Blood culture media sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Assay kits and reagents sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Software market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Sepsis diagnostics market: Technology outlook and key takeaways
Fig. 24 Sepsis diagnostics market: Technology movement analysis
Fig. 25 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Polymerase chain reaction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Syndromic panel testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Immunoassays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Sepsis diagnostics market: Pathogen outlook and key takeaways
Fig. 35 Sepsis diagnostics market: Pathogen movement analysis
Fig. 36 Bacterial sepsis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Gram-positive bacteria market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Gram-negative bacteria market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Fungal sepsis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Viral sepsis and others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Sepsis diagnostics market: Testing type outlook and key takeaways
Fig. 42 Sepsis diagnostics market: Testing type movement analysis
Fig. 43 Laboratory testing market estimates and forecast, 2018 - 2030, USD Million
Fig. 44 Point-of-care testing market estimates and forecast, 2018 - 2030, USD Million
Fig. 45 Sepsis diagnostics market: Method outlook and key takeaways
Fig. 46 Sepsis diagnostics market: Method movement analysis
Fig. 47 Automated diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Conventional diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Sepsis diagnostics market: End user outlook and key takeaways
Fig. 50 Sepsis diagnostics market: End-user movement analysis
Fig. 51 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Pathology & reference laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Research institutes and others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Sepsis diagnostic market revenue, by region, 2023 & 2030 (USD Million)
Fig. 55 Regional marketplace: Key takeaways
Fig. 56 North America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 U.S. sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Canada sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Europe sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 UK sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Germany sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 France sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Spain sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Italy sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Denmark sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Sweden sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Norway sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Russia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Rest of Europe sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Asia Pacific sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Japan sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 China sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 India sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Australia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Thailand sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 South Korea sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Singapore sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 96 Rest of Asia Pacific sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 Latin America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Brazil sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Mexico sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Argentina sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 104 Rest of LATAM sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 105 MEA sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 106 Key country dynamics
Fig. 107 South Africa sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 108 Key country dynamics
Fig. 109 Saudi Arabia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 UAE sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 112 Key country dynamics
Fig. 113 Kuwait sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 114 Rest of MEA sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 115 Market participant categorization
Fig. 116 Company market positioning
Fig. 117 Sepsis diagnostics market share analysis, 2023
Fig. 118 Company heat map analysis
Fig. 119 Strategic framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Sepsis Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030 )
    • Instruments
    • Blood Culture Media
    • Assay Kits and Reagents
    • Software
  • Sepsis Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030 )
    • Microbiology
    • Molecular Diagnostics
      • Polymerase Chain Reaction (PCR)
      • DNA Microarrays
      • Syndromic Panel Testing
      • Others
    • Immunoassays
    • Flow Cytometry
    • Others
  • Sepsis Diagnostics Pathogen Outlook (Revenue, USD Million, 2018 - 2030 )
    • Bacterial Sepsis
      • Gram-positive Bacteria
      • Gram-negative Bacteria
    • Fungal Sepsis
    • Viral Sepsis
    • Others
  • Sepsis Diagnostics Testing Type Outlook (Revenue, USD Million, 2018 - 2030 )
    • Laboratory Testing
    • PoC Testing
  • Sepsis Diagnostics Method Outlook (Revenue, USD Million, 2018 - 2030 )
    • Automated Diagnostics
    • Conventional Diagnostics
  • Sepsis Diagnostics End-user Outlook (Revenue, USD Million, 2018 - 2030 )
    • Hospitals & Clinics
    • Pathology & Reference Laboratories
    • Research Institutes and Others
  • Sepsis Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030 )
    • North America
      • North America Sepsis Diagnostics Market, By Product
        • Instruments
        • Blood Culture Media
        • Assay Kits and Reagents
        • Software
      • North America Sepsis Diagnostics Market, By Technology
        • Microbiology
        • Molecular Diagnostics
          • Polymerase Chain Reaction (PCR)
          • DNA Microarrays
          • Syndromic Panel Testing
          • Others
        • Immunoassays
        • Flow Cytometry
        • Others
      • North America Sepsis Diagnostics Market, By Pathogen
        • Bacterial Sepsis
          • Gram-positive Bacteria
          • Gram-negative Bacteria
        • Fungal Sepsis
        • Viral Sepsis
        • Others
      • North America Sepsis Diagnostics Market, By Testing Type
        • Laboratory Testing
        • PoC Testing
      • North America Sepsis Diagnostics Market, By Method
        • Laboratory Testing
        • PoC Testing
      • North America Sepsis Diagnostics Market, By End-user
        • Hospitals & Clinics
        • Pathology & Reference Laboratories
        • Research Institutes and Others
      • U.S.
        • U.S. Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • U.S. Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • U.S. Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • U.S. Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • U.S. Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • U.S. Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Canada
        • Canada Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Canada Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Canada Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Canada Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Canada Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Canada Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
    • Europe
      • Europe Sepsis Diagnostics Market, By Product
        • Instruments
        • Blood Culture Media
        • Assay Kits and Reagents
        • Software
      • Europe Sepsis Diagnostics Market, By Technology
        • Microbiology
        • Molecular Diagnostics
          • Polymerase Chain Reaction (PCR)
          • DNA Microarrays
          • Syndromic Panel Testing
          • Others
        • Immunoassays
        • Flow Cytometry
        • Others
      • Europe Sepsis Diagnostics Market, By Pathogen
        • Bacterial Sepsis
          • Gram-positive Bacteria
          • Gram-negative Bacteria
        • Fungal Sepsis
        • Viral Sepsis
        • Others
      • Europe Sepsis Diagnostics Market, By Testing Type
        • Laboratory Testing
        • PoC Testing
      • Europe Sepsis Diagnostics Market, By Method
        • Automated Diagnostics
        • Conventional Diagnostics
      • Europe Sepsis Diagnostics Market, By End-user
        • Hospitals & Clinics
        • Pathology & Reference Laboratories
        • Research Institutes and Others
      • Germany
        • Germany Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Germany Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Germany Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Germany Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Germany Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Germany Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • UK
        • UK Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • UK Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • UK Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • UK Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • UK Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • UK Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Spain 
        • Spain Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Spain Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Spain Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Spain Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Spain Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Spain Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • France 
        • France Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • France Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • France Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • France Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • France Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • France Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Italy 
        • Italy Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Italy Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Italy Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Italy Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Italy Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Italy Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Russia 
        • Russia Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Russia Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Russia Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Russia Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Russia Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Russia Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Denmark 
        • Denmark Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Denmark Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Denmark Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Denmark Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Denmark Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Denmark Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Sweden 
        • Sweden Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Sweden Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Sweden Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Sweden Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Sweden Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Sweden Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Norway 
        • Norway Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Norway Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Norway Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Norway Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Norway Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Norway Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
    • Asia Pacific 
      • Asia Pacific Sepsis Diagnostics Market, By Product
        • Instruments
        • Blood Culture Media
        • Assay Kits and Reagents
        • Software
      • Asia Pacific Sepsis Diagnostics Market, By Technology
        • Microbiology
        • Molecular Diagnostics
          • Polymerase Chain Reaction (PCR)
          • DNA Microarrays
          • Syndromic Panel Testing
          • Others
        • Immunoassays
        • Flow Cytometry
        • Others
      • Asia Pacific Sepsis Diagnostics Market, By Pathogen
        • Bacterial Sepsis
          • Gram-positive Bacteria
          • Gram-negative Bacteria
        • Fungal Sepsis
        • Viral Sepsis
        • Others
      • Asia Pacific Sepsis Diagnostics Market, By Testing Type
        • Laboratory Testing
        • PoC Testing
      • Asia Pacific Sepsis Diagnostics Market, By Method
        • Automated Diagnostics
        • Conventional Diagnostics
      • Asia Pacific Sepsis Diagnostics Market, By End-user
        • Hospitals & Clinics
        • Pathology & Reference Laboratories
        • Research Institutes and Others
      • Japan 
        • Japan Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Japan Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Japan Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Japan Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Japan Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Japan Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • China 
        • China Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • China Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • China Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • China Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • China Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • China Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • India 
        • India Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • India Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • India Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • India Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • India Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • India Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • South Korea 
        • South Korea Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • South Korea Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • South Korea Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • South Korea Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • South Korea Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • South Korea Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Singapore 
        • Singapore Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Singapore Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Singapore Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Singapore Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Singapore Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Singapore Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Australia 
        • Australia Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Australia Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Australia Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Australia Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Australia Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Australia Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Thailand 
        • Thailand Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Thailand Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Thailand Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Thailand Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Thailand Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Thailand Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
    • Latin America 
      • Latin America Sepsis Diagnostics Market, By Product
        • Instruments
        • Blood Culture Media
        • Assay Kits and Reagents
        • Software
      • Latin America  Sepsis Diagnostics Market, By Technology
        • Microbiology
        • Molecular Diagnostics
          • Polymerase Chain Reaction (PCR)
          • DNA Microarrays
          • Syndromic Panel Testing
          • Others
        • Immunoassays
        • Flow Cytometry
        • Others
      • Latin America Sepsis Diagnostics Market, By Pathogen
        • Bacterial Sepsis
          • Gram-positive Bacteria
          • Gram-negative Bacteria
        • Fungal Sepsis
        • Viral Sepsis
        • Others
      • Latin America Sepsis Diagnostics Market, By Testing Type
        • Laboratory Testing
        • PoC Testing
      • Latin America Sepsis Diagnostics Market, By Method
        • Automated Diagnostics
        • Conventional Diagnostics
      • Latin America Sepsis Diagnostics Market, By End-user
        • Hospitals & Clinics
        • Pathology & Reference Laboratories
        • Research Institutes and Others
      • Brazil 
        • Brazil Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Brazil Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Brazil Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Brazil Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Brazil Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Brazil Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Mexico 
        • Mexico Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Mexico Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Mexico Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Mexico Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Mexico Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Mexico Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Argentina 
        • Argentina Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Argentina Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Argentina Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Argentina Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Argentina Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Argentina Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
    • MEA 
      • MEA Sepsis Diagnostics Market, By Product
        • Instruments
        • Blood Culture Media
        • Assay Kits and Reagents
        • Software
      • MEA Sepsis Diagnostics Market, By Technology
        • Microbiology
        • Molecular Diagnostics
          • Polymerase Chain Reaction (PCR)
          • DNA Microarrays
          • Syndromic Panel Testing
          • Others
        • Immunoassays
        • Flow Cytometry
        • Others
      • MEA Sepsis Diagnostics Market, By Pathogen
        • Bacterial Sepsis
          • Gram-positive Bacteria
          • Gram-negative Bacteria
        • Fungal Sepsis
        • Viral Sepsis
        • Others
      • MEA  Sepsis Diagnostics Market, By Testing Type
        • Laboratory Testing
        • PoC Testing
      • MEA Sepsis Diagnostics Market, By Method
        • Automated Diagnostics
        • Conventional Diagnostics
      • MEA Sepsis Diagnostics Market, By End-user
        • Hospitals & Clinics
        • Pathology & Reference Laboratories
        • Research Institutes and Others
      • South Africa 
        • South Africa Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • South Africa Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • South Africa Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • South Africa Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • South Africa Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • South Africa Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Saudi Arabia 
        • Saudi Arabia Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Saudi Arabia Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Saudi Arabia Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Saudi Arabia Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Saudi Arabia Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Saudi Arabia Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • UAE 
        • UAE Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • UAE Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • UAE Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • UAE Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • UAE Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • UAE Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others
      • Kuwait ​​​​​​​
        • Kuwait Sepsis Diagnostics Market, By Product
          • Instruments
          • Blood Culture Media
          • Assay Kits and Reagents
          • Software
        • Kuwait Sepsis Diagnostics Market, By Technology
          • Microbiology
          • Molecular Diagnostics
            • Polymerase Chain Reaction (PCR)
            • DNA Microarrays
            • Syndromic Panel Testing
            • Others
          • Immunoassays
          • Flow Cytometry
          • Others
        • Kuwait Sepsis Diagnostics Market, By Pathogen
          • Bacterial Sepsis
            • Gram-positive Bacteria
            • Gram-negative Bacteria
          • Fungal Sepsis
          • Viral Sepsis
          • Others
        • Kuwait Sepsis Diagnostics Market, By Testing Type
          • Laboratory Testing
          • PoC Testing
        • Kuwait Sepsis Diagnostics Market, By Method
          • Automated Diagnostics
          • Conventional Diagnostics
        • Kuwait Sepsis Diagnostics Market, By End-user
          • Hospitals & Clinics
          • Pathology & Reference Laboratories
          • Research Institutes and Others

Sepsis Diagnostics Market Dynamics

Driver: Increase in Prevalence of Sepsis

Sepsis is a life-threatening condition that can affect anyone; however, certain groups are found to be more at risk of the condition. Individuals with weakened immune systems, such as cancer patients undergoing chemotherapy, are at a higher risk of developing sepsis. Similarly, people over the age of 65, pregnant women, and individuals with chronic medical conditions like diabetes and heart disease are also at an increased risk. Sepsis is the leading cause of death in high-income countries, such as the U.S., with approximately 270,000 people dying from the condition annually, according to the Centers for Disease Control and Prevention (CDC). Sepsis is also prevalent in low- and middle-income countries, where it often is undiagnosed and untreated due to limited access to healthcare. In 2020, the Global Sepsis Alliance reported that sepsis is responsible for an estimated 11 million deaths worldwide each year, which is more than the combined number of deaths from breast cancer, prostate cancer, and HIV/AIDS.

Driver: Rise in Incidence of Hospital-Acquired Infections

Sepsis continues to be a major healthcare concern in the U.S., affecting millions of individuals each year, according to 2021 data from the Centers for Disease Control and Prevention (CDC). Hospital-acquired infections continue to be a major contributor to the development of sepsis, particularly among patients with chronic conditions, such as diabetes. The CDC reports that approximately 1 in 31 hospital patients in the U.S. acquire hospital-acquired infection each year. These infections often result from invasive medical procedures, such as catheter insertions, and can lead to sepsis. Catheter-associated urinary Tract Infections (CAUTIs) and Surgical Site Infections (SSIs) are the most common types of hospital-acquired infections. SSIs are a major concern as they can lead to severe complications, including sepsis and septic shock. The CDC estimates that up to 5% of patients undergoing surgery develop an SSI, with higher risk in patients with underlying health conditions and those undergoing lengthy surgeries.

Restraint: High Cost of Automated Diagnostic Instruments

Sepsis is more common in low- and middle-income countries as treatment and diagnosis are difficult, particularly in places with few resources. Automated diagnostic tools for sepsis can be very expensive, exerting a significant financial strain on hospitals and healthcare systems in developing countries. Because of this, many healthcare facilities still use outdated methods to diagnose sepsis, which results in underdiagnoses and inadequate management of the condition. Sepsis is a serious issue in both the medical and financial sectors. It has the greatest in-patient mortality rates, highest in-patient expenses, and the lowest diagnosis & treatment reimbursement rates. Before 2018, sepsis was the primary factor in approximately 270,000 hospital deaths in the U.S., with roughly 27% of those deaths taking place in medical facilities and 43% in intensive care units. Sepsis was also the most under-reimbursed condition with the highest in-hospital costs in 2018, totaling more than USD 42 billion.

What Does This Report Include?

This section will provide insights into the contents included in this sepsis diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Sepsis diagnostics market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Sepsis diagnostics market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the sepsis diagnostics market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for sepsis diagnostics market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of sepsis diagnostics market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Sepsis Diagnostics Market Categorization:

The sepsis diagnostics market was categorized into seven segments, namely product (Instruments, Blood Culture Media, Assay Kits and Reagents, Software), technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), pathogen (Bacterial Sepsis, Fungal Sepsis, Viral Sepsis), testing type (Laboratory Testing, PoC Testing), method (Automated Diagnostics, Conventional Diagnostics), end-user (Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes and Others), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The sepsis diagnostics market was segmented into product, technology, pathogen, testing type, method, end-user, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The sepsis diagnostics market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-five countries, namely, the U.S.; Canada; the UK; Germany; Spain; France; Italy; Russia; Denmark; Sweden; Norway; Japan; India; China; South Korea; Singapore; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Sepsis diagnostics market companies & financials:

The sepsis diagnostics market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • bioMérieux SA - bioMérieux SA is a French biotechnology company that provides innovative diagnostic solutions for a number of medical needs. The company's offerings include reagents, instruments, software, and services that cater to consumer safety, cancer screening, monitoring, and cardiovascular emergencies. bioMérieux has a global footprint, with a presence in more than 44 countries and a network of distributors in over 160 countries.

  • Becton, Dickinson, and Company (BD) - Becton, Dickinson and Company (BD) is a renowned American multinational medical technology company focused on the development, manufacture, and sale of an extensive range of medical supplies, devices, laboratory equipment, and diagnostic products. It is a medical technology company that serves clinical laboratories, life sciences researchers, and healthcare institutions & industries. The company manufactures & markets a wide range of devices, diagnostic products, medical supplies, and laboratory equipment. It operates across three business segments: BD Life Sciences, BD Medical, and BD Interventional.

  • Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. manufactures and supplies scientific equipment, analytical instruments, and other laboratory equipment worldwide. It operates through four business segments: Analytical instruments, specialty diagnostics, laboratory products & biopharma services, and life sciences solutions. The company has a global presence with a robust distribution network across North America, APAC, and Europe.

  • F. Hoffmann-La Roche - F. Hoffmann-La Roche Ltd. is a Swiss global healthcare company that operates through two divisions: Pharmaceuticals and diagnostics. Roche Diagnostics comprises Roche Professional Diagnostics (RPD), Roche Molecular Diagnostics (RMD), Roche Tissue Diagnostics, and Roche Diabetes Care.

  • Luminex Corporation (a part of DiaSorin after 2021) - Luminex Corporation is a biotechnology company that is focused on the development, manufacture, and marketing of proprietary biological testing technologies with applications in life sciences. The company's innovative solutions are widely used in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic & proteomic research, and food safety. The company's commitment to cutting-edge technology and scientific innovation has made it a trusted name in the biotechnology industry.

  • Danaher - Danaher is a multinational conglomerate focused on providing innovative solutions to a range of industries. The company's offerings include products and services in the fields of life sciences, diagnostics, dental, and environmental & applied solutions. Danaher's mission is to help its customers solve complex challenges and improve the quality of life for people around the world. With a strong commitment to innovation and customer satisfaction, Danaher has established itself as a leader in the industries it serves.

  • Cepheid - Cepheid is a company that specializes in providing diagnostic solutions for multiple clinical applications, including healthcare-associated infections, sexual health, critical infectious disease, virology, and oncology. The company's main product is the GeneXpert rapid molecular diagnostic system, which was developed in the 1990s and has remained substantially the same since centuries. Cepheid is dedicated to advancing scientific research and improving patient outcomes by providing cutting-edge diagnostic tools that enable healthcare professionals to make quick & accurate diagnoses. With a strong commitment to innovation and excellence, Cepheid has established itself as a trusted name in the healthcare industry.

  • Beckman Coulter, Inc. - Beckman Coulter, Inc., a Danaher Corporation company, is dedicated to simplifying, automating, and innovating complex biomedical testing. The company's products are designed to enhance the diagnostic laboratory's role in improving healthcare outcomes, and its advanced-level diagnostic systems are used in hospitals, reference laboratories, and physician office settings worldwide. With strong commitment to innovation and customer satisfaction, Beckman Coulter has established itself as a leader in the field of biomedical testing. The company's cutting-edge technology and expertise in the development of diagnostic solutions have helped improve patient outcomes and advance scientific research.

  • Bruker Corporation - Bruker Corporation is a leading American manufacturer of scientific instruments used in molecular and materials research, as well as industrial and applied analysis. The company is dedicated to developing state-of-the-art technologies, innovative solutions, and analytical tools to help customers solve complex scientific challenges. With focus on quality and innovation, Bruker Corporation is committed to delivering high-performance solutions that meet the needs of customers across a wide range of industries, including pharmaceuticals, biotechnology, materials science, and environmental science. Through cutting-edge technologies and extensive expertise in scientific research, Bruker Corporation is helping drive progress and advance scientific knowledge around the world.

  • Immunexpress, Inc. - Immunexpress, Inc. is a molecular diagnostic company focused on developing and commercializing innovative diagnostic assays for acute care settings. Their flagship product, SeptiCyte, is a gene expression assay designed to rapidly differentiate sepsis from other infections, allowing clinicians to make faster and more accurate decisions for patients.

  • Koninklijke Philips N.V. - Koninklijke Philips N.V., commonly known as Philips, is a leading health technology company that aims to improve people's health and well-being through meaningful innovation. The company's portfolio includes a range of solutions for medical imaging, patient monitoring, health informatics, home healthcare, and personal health.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Sepsis Diagnostics Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Sepsis Diagnostics Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.